Total Payments
$1,410
2024 Payments
$184.58
Companies
15
Transactions
69
Medicare Patients
5,483
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$1,410 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,410 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $426.27 | 24 | $0 (2019) |
| ABBVIE INC. | $417.78 | 20 | $0 (2024) |
| UCB, Inc. | $143.06 | 6 | $0 (2024) |
| Smith+Nephew, Inc. | $68.11 | 3 | $0 (2022) |
| Almirall LLC | $59.30 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $51.48 | 3 | $0 (2024) |
| Incyte Corporation | $49.76 | 2 | $0 (2024) |
| EPI Health, LLC | $34.71 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.61 | 1 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $29.27 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184.58 | 7 | ABBVIE INC. ($54.26) |
| 2023 | $152.86 | 7 | ABBVIE INC. ($111.57) |
| 2022 | $374.52 | 18 | ABBVIE INC. ($251.95) |
| 2021 | $130.19 | 6 | UCB, Inc. ($67.32) |
| 2020 | $66.95 | 3 | Smith+Nephew, Inc. ($28.28) |
| 2019 | $189.06 | 12 | Galderma Laboratories, L.P. ($150.43) |
| 2018 | $146.48 | 9 | Galderma Laboratories, L.P. ($128.51) |
| 2017 | $165.77 | 7 | Galderma Laboratories, L.P. ($147.33) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.52 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $37.11 | General |
| Category: Immunology | ||||||
| 03/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Dermatology | ||||||
| 12/15/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Dermatology | ||||||
| 09/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Monoclonal Antibody | ||||||
| 06/09/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2022 | TRIAD LIFE SCIENCES INC. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 12/16/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2022 | EPI Health, LLC | CLODERM (Drug), MINOLIRA EXTENDED RELEASE, WYNZORA | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2022 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Dermatology | ||||||
| 10/04/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2022 | Sun Pharmaceutical Industries Inc. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Dermatology | ||||||
| 09/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,053 | 1,337 | $1.7M | $398,213 |
| 2022 | 32 | 1,495 | 2,039 | $2.3M | $561,247 |
| 2021 | 25 | 1,478 | 1,919 | $2.2M | $562,951 |
| 2020 | 24 | 1,457 | 1,949 | $1.7M | $557,010 |
Total Patients
5,483
Total Services
7,244
Medicare Billing
$2.1M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 263 | 312 | $701,688 | $179,950 | 25.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 100 | 173 | $236,318 | $66,484 | 28.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 74 | 90 | $190,080 | $50,960 | 26.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 92 | 102 | $159,936 | $22,775 | 14.2% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 13 | 13 | $42,770 | $11,150 | 26.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 62 | 68 | $68,748 | $11,097 | 16.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 44 | 46 | $65,090 | $10,037 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 130 | $38,610 | $9,853 | 25.5% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 35 | 35 | $57,855 | $8,252 | 14.3% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 17 | $22,253 | $6,304 | 28.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 69 | 85 | $15,810 | $4,117 | 26.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 17 | 17 | $17,884 | $2,486 | 13.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 29 | 32 | $10,816 | $2,327 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $8,820 | $2,260 | 25.6% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 14 | 14 | $14,434 | $2,165 | 15.0% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 11 | 11 | $15,499 | $2,116 | 13.7% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 12 | 12 | $14,556 | $2,045 | 14.0% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 17 | 22 | $6,424 | $1,470 | 22.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 32 | $6,080 | $1,326 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 18 | 20 | $4,460 | $790.11 | 17.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 12 | 38 | $874.00 | $211.66 | 24.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 47 | $1,128 | $36.23 | 3.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 326 | 389 | $855,800 | $219,619 | 25.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 142 | 234 | $313,794 | $89,437 | 28.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 86 | 106 | $219,208 | $60,050 | 27.4% |
About Dr. Michelle Levender, MD
Dr. Michelle Levender, MD is a Dermatology healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750546081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Levender, MD has received a total of $1,410 in payments from pharmaceutical and medical device companies, with $184.58 received in 2024. These payments were reported across 69 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,410).
As a Medicare-enrolled provider, Levender has provided services to 5,483 Medicare beneficiaries, totaling 7,244 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Silver Spring, MD
- Active Since 07/25/2008
- Last Updated 10/31/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1750546081
Products in Payments
- RINVOQ (Biological) $277.58
- ORACEA (Drug) $206.28
- SKYRIZI (Biological) $129.19
- Cimzia (Drug) $105.95
- EPIDUO FORTE (Drug) $102.66
- TRI-LUMA (Drug) $63.03
- Seysara (Drug) $59.30
- COSENTYX (Drug) $51.48
- OPZELURA (Drug) $49.76
- SOOLANTRA (Drug) $41.34
- COLLAGENASE SANTYL (Drug) $39.83
- Bimzelx (Biological) $37.11
- CLODERM (Drug) $34.71
- SPEVIGO (Drug) $33.61
- BLU-U (Medical Supply) $29.27
- Santyl (Drug) $28.28
- DORYX (Drug) $21.24
- Poteligeo (Drug) $19.89
- INNOVAMATRIX AC (Device) $19.52
- Erivedge (Biological) $18.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Silver Spring
Dr. Benjamin Lockshin, Md, MD
Dermatology — Payments: $4.1M
Dermatology $4.1M
Dr. Amy Cole, Md, MD
Dermatology — Payments: $15,910
Dermatology $15,910
Dr. Eleanor Ford, Md, MD
Dermatology — Payments: $4,364
Dermatology $4,364
Dr. Norman Lockshin, Md, MD
Dermatology — Payments: $3,753
Dermatology $3,753
Kavita Goyal, M.d, M.D
Dermatology — Payments: $1,414
Dermatology $1,414
Edward Cowen, M.d, M.D
Dermatology — Payments: $762.26
Dermatology $762.26